SLS   $1.17  -4.10% Market Closed After Close 1.17 0.0

Sellas Life Sciences Group Inc
Total Cash 9.15M
totalCashPerShare 0.142
EBITDA
Total Debt 692.00K
quickRatio 0.759
currentRatio 1.021
Total Revenue
debtToEquity 23.756
Revenue/Share
ROA -1.2915199
ROE -8.8806095
grossProfits
freeCashflow -26.45M
operatingCashflow -32.16M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 67.46M
forwardPE -2.6976743
floatShares 64.15M
sharesOutstanding 64.33M
sharesShort 6.08M
sharesShortPriorMonth 8.16M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.10%
Short Ratio help_outline 12.41%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 0.05
Price To Book help_outline 23.20
earningsQuarterlyGrowth
netIncomeToCommon -34.44M
trailingEps -0.90%
forwardEps -0.43%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.13 3Q 2024
institutionsCount 35
lastUpdated Nov. 7, 2024, 2:46 a.m.